Alpha DNA Investment Management’s CNX Resources CNX Stock Holding History

Alpha DNA Investment Management’s Portfolio CNX Stock Details CNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-26,003	Closed	-$587K	–	197
2023 Q3	$587K	Buy	+26,003	New	+$539K	0.24%	90
2021 Q1	–	Sell	-140	Closed	-$1K	–	698
2020 Q4	$1K	Buy	+140	New	+$1.41K	﹤0.01%	514

Other funds holding CNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's CNX Position: Q4 2023 in Review

Alpha DNA Investment Management sold out of CNX Resources (CNX) in Q4 2023, closing a stake of 26,003 shares — an estimated $587K sold.

Alpha DNA Investment Management first reported a position in CNX in Q4 2020 and held it in 2 quarters. The position peaked at $587K in Q3 2023. 320 funds tracked by Wall St. Rank hold CNX as of Q4 2023.

Alpha DNA Investment Management reported no remaining CNX Resources position as of Q4 2023 after selling out during the quarter.
Alpha DNA Investment Management sold 26,003 CNX Resources shares in Q4 2023, an estimated $587K.
Alpha DNA Investment Management first reported a position in CNX Resources in Q4 2020 and held it in 2 quarters.
Alpha DNA Investment Management's CNX Resources position peaked at $587K in Q3 2023.
320 funds tracked by Wall St. Rank held CNX Resources as of Q4 2023.

Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.